Vasco Data Security International (VDSI) 26.14

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Vasco Data Security International (VDSI) 26.14 $VDSI

Stocks March Upward; Grubhub Up On Earnings; Baidu Is Smashed
at Investor's Business Daily - Tue Jul 28, 10:52AM CDT
After an indecisive start, stocks turned higher going into the lunch hour Tuesday as earnings reports dominated the news. The Nasdaq rose 0.3%, the S&P 500 gained 0.5% and the Dow Jones industrial average galloped to a 0.6% gain in the stock market...
VDSI: 26.14 (+1.02), BIDU: 163.44 (-34.24), GRUB: 33.76 (+2.75), PGTI: 15.05 (+1.00), BP: 37.29 (+1.24)

VASCO (VDSI) Q2 Earnings: Another Incredible Beat in Store? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 27, 4:44PM CDT
VASCO (VDSI) is set to report its second-quarter 2015 results after the market closes on Jul 28. Let's see how things are shaping up for this announcement.
VDSI: 26.14 (+1.02), FEYE: 45.34 (-1.01), EA: 71.93 (+0.71), LINE: 5.75 (+0.24)

Why VASCO Data Security (VDSI) Could Be an Impressive Growth Stock - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jul 27, 7:32AM CDT
VASCO Data Security (VDSI) seems well-positioned for future earnings growth and it is seeing rising earnings estimates, coupled with a solid Zacks Rank.
VDSI: 26.14 (+1.02)

Meet 5 IBD 50 Stocks Reporting Earnings This Week
at Investor's Business Daily - Sat Jul 25, 9:02AM CDT
Earnings season has kicked into high gear, and a number of top-rated stocks such as Vasco Data Security (VDSI) and Facebook (FB) are due to report earnings this coming week. The computer-generated IBD 50 list of premier stocks is based on a...
VDSI: 26.14 (+1.02), ELLI: 71.03 (-0.60), GILD: 112.42 (+1.88), FB: 95.27 (+1.10), ORLY: 241.41 (+1.57), UTHR: 168.57 (+2.79), EW: 154.24 (+1.52), CRI: 108.30 (+1.60), TASR: 31.03 (+0.70)

Valeant, Starbucks Lead 5 IBD 50 Stocks Bucking Market
at Investor's Business Daily - Fri Jul 24, 6:14PM CDT
A handful of IBD 50 stocks got a boost last week, bucking overall market weakness, thanks to better-than-expected quarterly results. Illumina (ILMN), which makes genetic testing equipment, was among the few disappointments. It plunged 8% Wednesday...
VRX: 257.40 (+0.10), ELLI: 71.03 (-0.60), FB: 95.27 (+1.10), UHS: 140.98 (+0.69), UTHR: 168.57 (+2.79), ORLY: 241.41 (+1.57), EW: 154.24 (+1.52), ILMN: 217.63 (+0.36), MANH: 64.51 (-0.44), SBUX: 57.08 (+0.10), VDSI: 26.14 (+1.02), CRUS: 34.21 (+1.31), TASR: 31.03 (+0.70), AAPL: 123.80 (+1.03)

DST Systems Falls on Q2 Earnings Miss, Revenues Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jul 24, 10:45AM CDT
DST Systems Inc. (DST) reported non-GAAP earnings of $1.39 per share, missing the Zacks Consensus Estimate of $1.46.
VDSI: 26.14 (+1.02), FISV: 85.59 (+0.53), IBM: 160.06 (+0.99), DST: 104.97 (+0.23)

Critical Alerts For 3D Systems, Pandora, SanDisk, VASCO Data Security and Hewlett Packard Released By InvestorsObserver
PR Newswire - Fri Jul 24, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for DDD, P, SNDK, VDSI and HPQ.
VDSI: 26.14 (+1.02), P: 16.79 (+0.82), DDD: 14.76 (+0.19), HPQ: 30.28 (+0.03), SNDK: 61.13 (-0.03)

Fortinet (FTNT) Looks Good: Stock Adds 10.7% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jul 24, 8:04AM CDT
Fortinet Inc. (FTNT) was a big mover last session, as the company saw its shares rise nearly 11% on the day.
VDSI: 26.14 (+1.02), FTNT: 47.07 (-0.03)

4 Cybersecurity Stocks Rally As Fortinet Beats
at Investor's Business Daily - Thu Jul 23, 1:14PM CDT
Cybersecurity software firm Fortinet (FTNT) beat second-quarter earnings and sales estimates late Wednesday, and shares are surging in the stock market today. The beat is also lifting its cybersecurity peers: Palo Alto Networks (PANW), CyberArk...
VDSI: 26.14 (+1.02), FEYE: 45.34 (-1.01), CYBR: 59.99 (+0.16), PANW: 187.05 (+0.76), FTNT: 47.07 (-0.03)

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of VASCO Data Security International Inc.
PR Newswire - Wed Jul 22, 12:10PM CDT
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of VASCO Data Security International Inc. ("VASCO" or the "Company" (NasdaqCM: VDSI -News). Such investors are advised to contact Peretz Bronstein or his investor relations coordinator Eitan Kimelman at info@bgandg.com or 212-697-6484.
VDSI: 26.14 (+1.02)

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of VASCO Data Security International, Inc. - VDSI
ACCESSWIRE - Wed Jul 22, 11:24AM CDT
NEW YORK, NY / ACCESSWIRE / July 22, 2015 / Pomerantz LLP is investigating claims on behalf of investors of VASCO Data Security International, Inc. ("VASCO" or the "Company" (NASDAQ: VDSI). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980.
VDSI: 26.14 (+1.02)

The Zacks Analyst Blog Highlights: IBM, NCI, Equinix, VASCO Data Security International and Zix - Press Releases
Zacks Equity Research - Zacks Investment Research - Wed Jul 22, 8:30AM CDT
The Zacks Analyst Blog Highlights: IBM, NCI, Equinix, VASCO Data Security International and Zix
VDSI: 26.14 (+1.02), EQIX: 280.70 (+4.06), IBM: 160.06 (+0.99), ZIXI: 4.95 (+0.05), NCIT: 10.18 (+0.15)

Stock Futures Down, Action Mixed; Apple, Vasco, Illumina Tumble
at Investor's Business Daily - Wed Jul 22, 8:04AM CDT
Stock futures veered unevenly lower on a heavy slate of earnings reports ahead of Wednesday's open. Dow futures were down 30.3 points below fair market value, but had pared early losses. Nasdaq 100 futures were down 62.4 points and sliding. S&P 500...
KO: 40.53 (-0.01), WHR: 176.31 (+4.47), VDSI: 26.14 (+1.02), SWKS: 96.05 (+2.56), ILMN: 217.63 (+0.36), CRUS: 34.21 (+1.31), HAWK: 44.09 (+0.54), MSFT: 45.49 (+0.14), BA: 141.87 (+0.84), AAPL: 123.80 (+1.03)

2 Cybersecurity Stocks Stay Hot As Vasco Goes Cold
at Investor's Business Daily - Wed Jul 22, 7:02AM CDT
The security-software industry group is one of the top groups that IBD tracks, ranked No. 4 out of 197 total industry groups, as high-profile data breaches become more prevalent. But on Tuesday evening Vasco Data Security (VDSI) plunged 11% late,...
VDSI: 26.14 (+1.02), CYBR: 59.99 (+0.16), PANW: 187.05 (+0.76)

VASCO DATA SECURITY
at Investor's Business Daily - Tue Jul 21, 5:43PM CDT
VASCO DATA SECURITY (VDSI) said that a subsidiary sold products to a 3rd-party distributor that may have resold them to Iran. The cybersecurity software firm says that it is investigating. Shares plunged 9.6%.
VDSI: 26.14 (+1.02)

Lessons from IBM's Earnings: 4 Growth Picks - Analyst Blog
Swarup Gupta - Zacks Investment Research - Tue Jul 21, 7:29AM CDT
Important lessons are emerging from IBM's results which underline prevailing trends in the technology domain.
VDSI: 26.14 (+1.02), EQIX: 280.70 (+4.06), IBM: 160.06 (+0.99), ZIXI: 4.95 (+0.05), NCIT: 10.18 (+0.15), MSFT: 45.49 (+0.14)

Stocks Open Mixed In Rising Trade; Google Helps Nasdaq To New High
at Investor's Business Daily - Fri Jul 17, 9:35AM CDT
Stocks flew into Friday's session in tightly mixed formation, with earnings news squarely at the center of early action. The Nasdaq climbed 0.5%, passing its June 24 peak to notch a new high. The S&P 500 dipped 0.2%, the Dow Jones industrial average...
DHI: 27.73 (+0.99), TSLA: 264.54 (+11.53), GE: 26.14 (+0.19), FB: 95.27 (+1.10), KSU: 97.90 (+4.71), SLB: 82.70 (+0.94), PCLN: 1,205.37 (+19.29), NOAH: 22.90 (+0.74), VDSI: 26.14 (+1.02), LEN: 51.09 (+0.53), BIDU: 163.44 (-34.24), AMD: 1.74 (+0.12), MAT: 23.05 (-0.03), ERIC: 10.61 (-0.13), PHM: 19.76 (+0.26), GOOGL: 659.42 (+1.15), TOL: 38.57 (+0.72)

Stocks Up; Nasdaq, S&P 500 Lead; Netflix Spikes To Fresh High
at Investor's Business Daily - Thu Jul 16, 9:50AM CDT
Stocks pressed out uneven gains in early action Thursday, riding a cross-current of input from the U.S. and overseas. The Nasdaq powered up to a 0.7% gain. The S&P 500 climbed 0.5% and the Dow Jones industrial average clung to a 0.1% advance. Volume...
C: 58.28 (+0.32), TSM: 21.92 (+0.29), SLB: 82.70 (+0.94), NFLX: 107.39 (+0.96), PM: 85.66 (+0.13), VDSI: 26.14 (+1.02), GS: 205.87 (+0.85), AMD: 1.74 (+0.12), MAT: 23.05 (-0.03), NLNK: 53.53 (+2.56), DPZ: 111.81 (+0.50), GOOGL: 659.42 (+1.15), SHW: 273.42 (+7.38)

IBD 50 Security, Semiconductor Stocks Under Fire
at Investor's Business Daily - Fri Jul 10, 6:00PM CDT
A rocky week of trading created some turmoil in the IBD 50. Semiconductor stocks in particular have been under fire. Three longtime chip leaders in the IBD 50 have flashed sell signals after making huge moves in the market. Avago Technologies (AVGO)...
AGN: 337.67 (+10.69), AMBA: 121.39 (+1.94), VRX: 257.40 (+0.10), VDSI: 26.14 (+1.02), SWKS: 96.05 (+2.56), CYBR: 59.99 (+0.16), UHS: 140.98 (+0.69), GTN: 16.51 (+0.10), FLTX: 47.51 (+0.66), REGN: 556.00 (+15.97), AVGO: 128.86 (+4.21), OZRK: 44.03 (-0.23)

Critical Alerts For CyberArk Software, Build-A-Bear Workshop, Windstream, VASCO Data Security and El Pollo Loco Released By InvestorsObserver
PR Newswire - Thu Jul 09, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for CYBR, BBW, WIN, VDSI and LOCO.
VDSI: 26.14 (+1.02), CYBR: 59.99 (+0.16), BBW: 17.36 (-0.39), LOCO: 18.40 (+0.21), WIN: 4.66 (-0.04)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 9

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 123

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 52

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 422

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 175

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 104

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 0

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 432

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 287

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 557

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading

Top 5 Most Recently Viewed Articles

NKGen Biotech to Present Innovative Research at Global Congress

Updated Category News Views 157

NKGen Biotech's Exciting Announcement on Upcoming Presentation NKGen Biotech Inc. (NASDAQ: NKGN), a pioneering clinical-stage biotechnology firm dedicated to developing cutting-edge autologous and allogeneic natural killer cell therapies, has recently shared some thrilling news regarding their participation in an international event. Highlighting Neurodegenerative...

Continue Reading
Celebrating Case Managers: A Call to Action for 2025

Updated Category News Views 522

Recognizing the Contribution of Case Managers in 2025 Case managers have proven time and again to be essential contributors to the health and human services spectrum. In 2025, the two prominent organizations in the case management field—the American Case Management Association (ACMA) and the Commission for Case Manager Certification (CCMC)—have once again partnered to...

Continue Reading
Faruqi & Faruqi Investigates Ford Investor Claims

Updated Category News Views 92

Back in 2024, Faruqi & Faruqi took aim at Ford Motor Company (NYSE: F), investigating claims from investors who’d racked up losses over $100,000. They were diving deep into the financial mess at Ford—a colossal vehicle manufacturer that found itself knee-deep in allegations of breaching federal securities laws. The chatter was all about how quality assurance failures...

Continue Reading
Entourage Health Announces Going-Private Arrangement Plan

Updated Category News Views 236

Entourage Health Corp. Takes a Bold Step Toward Going-Private Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) has officially entered into a significant arrangement agreement with 1001007762 Ontario Inc. and 2437653 Ontario Inc. This strategic move, a statutory plan under the Business Corporations Act (Ontario), sees the Purchaser agreeing to acquire all common shares...

Continue Reading
A&W Revenue Royalties Income Fund Q3 2024 Results Review

Updated Category News Views 183

A&W Revenue Royalties Income Fund Q3 2024 Financial Overview TRADING SYMBOL: TSX: AW.UN A&W Revenue Royalties Income Fund has reported encouraging results for the third quarter ending this year. The quarterly performance reflects steady royalty income growth and strategic developments that promise an exciting future. Royalty Income Performance In the third quarter of...

Continue Reading